These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37870438)

  • 1. Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors.
    Galbraith K; Serrano J; Shen G; Tran I; Slocum CC; Ketchum C; Abdullaev Z; Turakulov R; Bale T; Ladanyi M; Sukhadia P; Zaidinski M; Mullaney K; DiNapoli S; Liechty BL; Barbaro M; Allen JC; Gardner SL; Wisoff J; Harter D; Hidalgo ET; Golfinos JG; Orringer DA; Aldape K; Benhamida J; Wrzeszczynski KO; Jour G; Snuderl M
    Mol Cancer Res; 2024 Jan; 22(1):21-28. PubMed ID: 37870438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature.
    Lopez-Nunez O; Cafferata B; Santi M; Ranganathan S; Pearce TM; Kulich SM; Bailey KM; Broniscer A; Rossi S; Zin A; Nasrallah MP; Li MM; Zhong Y; Miele E; Alaggio R; Surrey LF
    Brain Pathol; 2021 Jan; 31(1):70-83. PubMed ID: 32997853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
    Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
    Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
    Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
    Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next generation sequencing of MLH1-deficient, MLH1 promoter hypermethylated, and BRAF/RAS-wild-type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions.
    Vaňková B; Vaněček T; Ptáková N; Hájková V; Dušek M; Michal M; Švajdler P; Daum O; Daumová M; Michal M; Mezencev R; Švajdler M
    Genes Chromosomes Cancer; 2020 Oct; 59(10):562-568. PubMed ID: 32427409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
    Hou Y; Pinheiro J; Sahm F; Reuss DE; Schrimpf D; Stichel D; Casalini B; Koelsche C; Sievers P; Wefers AK; Reinhardt A; Ebrahimi A; Fernández-Klett F; Pusch S; Meier J; Schweizer L; Paulus W; Prinz M; Hartmann C; Plate KH; Reifenberger G; Pietsch T; Varlet P; Pagès M; Schüller U; Scheie D; de Stricker K; Frank S; Hench J; Pollo B; Brandner S; Unterberg A; Pfister SM; Jones DTW; Korshunov A; Wick W; Capper D; Blümcke I; von Deimling A; Bertero L
    Acta Neuropathol; 2019 May; 137(5):837-846. PubMed ID: 30759284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions.
    Stichel D; Schrimpf D; Casalini B; Meyer J; Wefers AK; Sievers P; Korshunov A; Koelsche C; Reuss DE; Reinhardt A; Ebrahimi A; Fernández-Klett F; Kessler T; Sturm D; Ecker J; Milde T; Herold-Mende C; Witt O; Pfister SM; Wick W; Jones DTW; von Deimling A; Sahm F
    Acta Neuropathol; 2019 Nov; 138(5):827-835. PubMed ID: 31278449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing data.
    Stichel D; Schrimpf D; Sievers P; Reinhardt A; Suwala AK; Sill M; Reuss DE; Korshunov A; Casalini BM; Sommerkamp AC; Ecker J; Selt F; Sturm D; Gnekow A; Koch A; Simon M; Hernáiz Driever P; Schüller U; Capper D; van Tilburg CM; Witt O; Milde T; Pfister SM; Jones DTW; von Deimling A; Sahm F; Wefers AK
    Neuropathol Appl Neurobiol; 2021 Apr; 47(3):406-414. PubMed ID: 33336421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial myxoid mesenchymal tumors with EWSR1-CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity?
    Bale TA; Oviedo A; Kozakewich H; Giannini C; Davineni PK; Ligon K; Alexandrescu S
    Brain Pathol; 2018 Mar; 28(2):183-191. PubMed ID: 28281318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma.
    Sievers P; Stichel D; Schrimpf D; Sahm F; Koelsche C; Reuss DE; Wefers AK; Reinhardt A; Huang K; Ebrahimi A; Hou Y; Pajtler KW; Pfister SM; Hasselblatt M; Stummer W; Schick U; Hartmann C; Hagel C; Staszewski O; Reifenberger G; Beschorner R; Coras R; Keyvani K; Kohlhof P; Diomedi-Camassei F; Herold-Mende C; Giangaspero F; Rushing E; Giannini C; Korshunov A; Jones DTW; von Deimling A
    Acta Neuropathol; 2018 Aug; 136(2):293-302. PubMed ID: 29978331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
    Solomon JP; Linkov I; Rosado A; Mullaney K; Rosen EY; Frosina D; Jungbluth AA; Zehir A; Benayed R; Drilon A; Hyman DM; Ladanyi M; Sireci AN; Hechtman JF
    Mod Pathol; 2020 Jan; 33(1):38-46. PubMed ID: 31375766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare Oncogenic Fusions in Pediatric Central Nervous System Tumors: A Case Series and Literature Review.
    Ahmed M; Sieben A; Van Genechten T; Libbrecht S; Gilis N; De Praeter M; Fricx C; Calò P; Van Campenhout C; D'Haene N; Witte O; Kempen LCV; Lammens M; Salmon I; Lebrun L
    Cancers (Basel); 2024 Sep; 16(19):. PubMed ID: 39409964
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
    Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization.
    Krystel-Whittemore M; Taylor MS; Rivera M; Lennerz JK; Le LP; Dias-Santagata D; Iafrate AJ; Deshpande V; Chebib I; Nielsen GP; Wu CL; Nardi V
    Hum Pathol; 2019 Nov; 93():65-73. PubMed ID: 31430493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population.
    Pan Y; Zhang Y; Ye T; Zhao Y; Gao Z; Yuan H; Zheng D; Zheng S; Li H; Li Y; Jin Y; Sun Y; Chen H
    J Thorac Oncol; 2019 Nov; 14(11):2003-2008. PubMed ID: 31382039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms.
    Sloan EA; Chiang J; Villanueva-Meyer JE; Alexandrescu S; Eschbacher JM; Wang W; Mafra M; Ud Din N; Carr-Boyd E; Watson M; Punsoni M; Oviedo A; Gilani A; Kleinschmidt-DeMasters BK; Coss DJ; Lopes MB; Raffel C; Berger MS; Chang SM; Reddy A; Ramani B; Ferris SP; Lee JC; Hofmann JW; Cho SJ; Horvai AE; Pekmezci M; Tihan T; Bollen AW; Rodriguez FJ; Ellison DW; Perry A; Solomon DA
    Brain Pathol; 2021 Jul; 31(4):e12918. PubMed ID: 33141488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell block-based RNA next generation sequencing for detection of gene fusions in lung adenocarcinoma: An institutional experience.
    Wei S; Talarchek JN; Huang M; Gong Y; Du F; Ehya H; Flieder DB; Patchefsky AS; Wasik MA; Pei J
    Cytopathology; 2023 Jan; 34(1):28-34. PubMed ID: 36062384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions.
    Tauziède-Espariat A; Chotard G; le Loarer F; Baud J; Azmani R; Dangouloff-Ros V; Boddaert N; Icher-de-Bouyn C; Gimbert E; Hasty L; Métais A; Chrétien F; Varlet P;
    Acta Neuropathol Commun; 2022 Feb; 10(1):15. PubMed ID: 35115049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.